4
Changes in Ownership
Caris Life Sciences, Inc. Filed Acc 0002071953-26-000007
President sold 597,212 shares at an average $24.84 ($14,834,107)
- President acquired 1,250,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Spetzler David Baxley President | 2026-09-03 | Option exercise | +1,000,000 | $2.44 | $2,440,000 | 1,530,083 | D: show line 1 in the form |
| Spetzler David Baxley President | 2026-09-03 | Sale | −393,100 | $24.76 | $9,733,313 | 1,136,983 | D: show line 2 in the form |
| Spetzler David Baxley President | 2026-09-03 | Sale | −84,900 | $25.32 | $2,149,676 | 1,052,083 | D: show line 3 in the form |
| Spetzler David Baxley President | 2026-09-04 | Option exercise | +250,000 | $2.44 | $610,000 | 1,302,083 | D: show line 4 in the form |
| Spetzler David Baxley President | 2026-09-04 | Sale | −119,212 | $24.76 | $2,951,117 | 1,182,871 | D: show line 5 in the form |
| Open-market sales · 597,212 sh · avg $24.84 · $14,834,107 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Spetzler David Baxley President | 2026-09-03 | Option exercise · Stock Option | −1,000,000 | 250,000 | D: show line 6 in the form | ||
| Spetzler David Baxley President | 2026-09-04 | Option exercise · Stock Option | −250,000 | 0 | D: show line 7 in the form |
Loading xslF345X06/wk-form4_1788555596.xml…